Zukunftsfonds Heilbronn

Zukunftsfond Heilbronn supports as a regional venture capital fund in the very busy South of Germany, the development of young innovative companies from start-up to matural stage. The investment philosophy of Zukunfsfonds Heilbronn is simple: they are investing in young, promising companies with innovative ideas, which have a good market potential and are controlled by a prominent management-team. They are investing in an early stage – from the seed, beyond the start-up to the phase of expansion – in fact as long as it is reasonable for both parties.

Thomas R. Villinger

Managing Director, CEO and Co-Founder

17 past transactions

Eleva

Venture Round in 2021
Eleva is a privately-held company focused on developing innovative biological therapies in collaboration with pharmaceutical partners. Utilizing a unique moss-based production platform, Eleva produces complex biologics such as antibodies, replacement enzymes, and fusion toxins. This platform enables the company to perform intricate posttranslational modifications, including glycosylation, which enhances the quality of the biologics produced. Eleva has successfully advanced its drug candidates into clinical phases, providing healthcare organizations with high-quality recombinant proteins for patient treatment.

MetisMotion

Seed Round in 2018
MetisMotion actuators are based on decades of experience in specialty actuator development for industrial environments. Our key strength are high force-density and ultra dynamic linear actuators.

ResuSciTec

Series B in 2016
ResuSciTec GmbH is a biotechnology company based in Freiburg im Breisgau, Germany, founded in 2010 as a spin-off from the University Hospital of Freiburg. The company specializes in developing therapies aimed at treating patients who experience acute circulatory arrest. Its research focuses on controlled whole-body reperfusion methods to enhance resuscitation outcomes for individuals suffering from cardiovascular emergencies. Led by Prof. Dr. med. Dr. hc Friedhelm Beyersdorf, the Medical Director of the Department of Cardiovascular Surgery at the University Heart Center Freiburg Bad Krozingen, ResuSciTec aims to improve existing therapies and establish innovative solutions in the field of cardiac care.

ProtaGene

Acquisition in 2013
ProtaGene is an analytic service provider across the biopharmaceutical, cell, and gene therapy development spaces. They provide complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms. They offer product testing and analytical packages for product lifecycle management.

Compositence

Private Equity Round in 2013
Compositence is a trademark. All trademarks (trademarks), logos, and service marks are the property of Compositence GmbH or the respective manufacturers and may not be used or copied without written permission of the owner. All content on this and following pages, including images, text, audio and video are protected. It is permitted for personal, non-commercial purposes, to view the page, use, and print documents from this site, if the trademarks appear on all documents.

ResuSciTec

Series A in 2012
ResuSciTec GmbH is a biotechnology company based in Freiburg im Breisgau, Germany, founded in 2010 as a spin-off from the University Hospital of Freiburg. The company specializes in developing therapies aimed at treating patients who experience acute circulatory arrest. Its research focuses on controlled whole-body reperfusion methods to enhance resuscitation outcomes for individuals suffering from cardiovascular emergencies. Led by Prof. Dr. med. Dr. hc Friedhelm Beyersdorf, the Medical Director of the Department of Cardiovascular Surgery at the University Heart Center Freiburg Bad Krozingen, ResuSciTec aims to improve existing therapies and establish innovative solutions in the field of cardiac care.

Medos Medizintechnik

Acquisition in 2011
Medos Medizintechnik develops and manufactures medical devices for cardiac surgery, extracorporeal membrane oxygenation, and ventricle assist devices. Its products include VAD-Atrium-Cannulae; VAD-Apex-Cannulae; Arterial-VAD-Cannulae; X-Flow; DELTASTREAM; HILITE; HILITE Reservoirs; tubing Sets, which include machine-sets, table-sets, cardioplegia-sets, infusion-/transfusion-/re-transfusion and perfusion-sets, haemofilter-sets, pressure-measuring-sets, and pre-bypass-sets; surgical Sets; VAD System; heparin coating; arterial filter; and haemofilter. The company offers tubing sets and surgical sets, as well as provides assembly of indication specific surgical sets.

enymotion

Venture Round in 2008
Enymotion specializes in the development and production of ultra-quiet, zero-emission mobile fuel cell systems designed for recreational applications such as caravans and boats. These systems provide a self-sufficient power supply, utilizing the caloric equivalent of conventional fuels or liquid gas to deliver energy without generating noise or exhaust. By offering a reliable battery backup solution for motor homes, sailing boats, and utility vehicles, Enymotion enables consumers to enjoy independent power consumption while minimizing environmental impact.

Dataglobal

Venture Round in 2008
Dataglobal GmbH specializes in developing data management solutions that facilitate digital transformation for businesses. The company provides an integrated software suite designed to manage various aspects of IT storage environments, including data analysis, monitoring, archiving, and performance optimization. Key offerings include ERS migration, which alleviates storage capacity issues; ERS archive, which enables efficient data archiving and search capabilities; ERS chargeback, which tracks and reports resource usage; and ERS storage performance, which presents storage metrics in multiple formats. With a strong focus on Enterprise Information Management and Archiving, Dataglobal supports clients in enhancing governance, risk management, compliance, and eDiscovery processes. Its solutions optimize systems like file servers and ERP applications, allowing organizations to leverage information from diverse sources. Headquartered in Heilbronn, Germany, with an additional office in Los Gatos, California, Dataglobal has successfully implemented its products in over 40 countries, serving notable clients such as AUDI AG and Deutsche Bank.
IoLiTec Ionic Liquids Technologies GmbH specializes in the development, production, and sale of ionic liquids for a wide range of applications, including synthesis, catalysis, analytics, electroplating, heat and refrigeration engineering, biotechnology, and sensor technology. The company also offers intermediates, nanotech and coatings, energy and cleantech products, and fine chemicals. In addition to its product offerings, IoLiTec provides consulting services, feasibility studies, and product development based on ionic liquids. Established in 2003 and based in Heilbronn, Germany, IoLiTec collaborates with partners across various industries, including chemical, engineering, electrical, and automotive sectors, serving both small and medium-sized enterprises as well as larger global companies.

Schwarzer Cardiotek

Venture Round in 2008
Schwarzer Cardiotek GmbH is a company based in Heilbronn, Germany, that specializes in the development, manufacturing, and distribution of measurement systems for functional diagnostics related to left and right heart catheterization. The firm focuses on hemodynamics and electrophysiology, offering integrated solutions that include measurement systems, data management, and documentation tools tailored for the interventional cardiology sector. With a global presence and over 1,000 installed systems, Schwarzer Cardiotek has built a strong reputation over its 60-plus years in the industry. Its products enable healthcare professionals to effectively measure invasive blood pressure, cardiac output, and other vital parameters, ultimately enhancing patient care. Founded in 1938, the company changed its name from Schwarzer GmbH to Schwarzer Cardiotek GmbH in June 2014.

seleon GmbH

Acquisition in 2007
Seleon GmbH is a Heilbronn, Germany-based company that specializes in the development and manufacturing of electronic and mechanical equipment for the healthcare industry. Established in 1998, the company has grown into a prominent provider of medical technology services. Its product portfolio includes Trans-Nasal Insufflation (TNI), designed for patients with mild sleep apnea and hypopnea, as well as Cpeak Tremor Analysis Software for analyzing human tremors. Additionally, Seleon offers radiation equipment and systems for image recording and analysis. The company collaborates closely with clients worldwide to create tailored solutions, leveraging the expertise of its team, which includes physicists, engineers, and consultants. Seleon also provides a range of consulting services, such as lifecycle management and regulatory guidance, aimed at enhancing project planning and execution for medical technology firms.

smartgas mikrosensorik

Seed Round in 2007
SmartGAS Mikrosensorik GmbH develops and produces reliable, accurate, and economical infrared absorption sensors (NDIR) for the detection of gases in a very wide range of application areas.

greenovation Biotech

Series B in 2006
greenovation Biotech has developed an innovative technology for the production of proteins using moss cells. The “moss bioreactor“, is a safe and cost-effective production platform for biopharmaceuticals with special characteristics that improve the activity of therapeutic proteins, such as antibodies.
We enable engineers to deliver incredible products. Faster.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.